Tissue-specific expression and hybrid plant production

US10913953B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10913953-B2
Application numberUS-201816046780-A
CountryUS
Kind codeB2
Filing dateJul 26, 2018
Priority dateDec 31, 2013
Publication dateFeb 9, 2021
Grant dateFeb 9, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.

First claim

Opening claim text (preview).

What may be claimed is: 1. A nucleic acid molecule comprising a coding sequence operably linked to a plant promoter, wherein the coding sequence comprises the internal small ribonucleic acid (sRNA) target site of SEQ ID NO:7. 2. The nucleic acid molecule of claim 1 , wherein the molecule is a vector. 3. The nucleic acid molecule of claim 2 , wherein the vector is a plant expression vector or plant transformation vector. 4. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule is incorporated into a plant genomic nucleic acid. 5. The nucleic acid molecule of claim 1 , wherein the coding sequence is an herbicide tolerance coding sequence or a selectable marker coding sequence. 6. The nucleic acid molecule of claim 1 , wherein the plant promoter is sugarcane bacilliform virus (SCBV) promoter. 7. A transgenic plant cell comprising the nucleic acid molecule of claim 1 . 8. The transgenic plant cell of claim 7 , wherein expression of the coding sequence is reduced or eliminated in the transgenic plant cell. 9. The transgenic plant cell of claim 7 , wherein expression of the coding sequence is reduced or eliminated in a plurality of transgenic plant cells, thereby resulting in reduced or eliminated expression of the coding sequence in a tissue-specific or tissue-preferred manner. 10. The transgenic plant cell of claim 9 , wherein expression of the coding sequence is reduced or eliminated in a plurality of transgenic plant cells, thereby resulting in reduced or eliminated expression of the coding sequence in male plant tissues. 11. A transgenic plant tissue or plant part comprising the nucleic acid molecule of claim 1 . 12. The transgenic plant tissue or plant part of claim 11 , wherein expression of the coding sequence is reduced or eliminated in male plant tissues. 13. The transgenic plant tissue or plant part of claim 11 , wherein the plant tissue or plant part is a seed. 14. A transgenic plant comprising the nucleic acid molecule of claim 4 . 15. The transgenic plant of claim 14 , wherein expression of the coding sequence is reduced or eliminated in at least one tissue of the plant. 16. The transgenic plant of claim 15 , wherein expression of the coding sequence is reduced or eliminated in a tissue-specific or tissue-preferred manner. 17. The transgenic plant of claim 16 , wherein expression of the coding sequence is reduced or eliminated in male plant tissues. 18. The transgenic plant of claim 17 , wherein the coding sequence is an herbicide tolerance coding sequence, and wherein application of the herbicide to the plant kills male tissues in the plant. 19. A method for producing a transgenic plant cell, the method comprising transforming a plant cell with the nucleic acid molecule of claim 1 . 20. The method according to claim 19 , the method further comprising: culturing the transformed plant cell to produce a transgenic plant cell or transgenic tissue culture of transgenic plant cells comprising the coding sequence operably linked to the plant promoter; and regenerating a transgenic plant from the transgenic plant cell or transgenic tissue culture.

Assignees

Inventors

Classifications

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • for herbicide resistance · CPC title

  • Gene switch · CPC title

  • Male sterility · CPC title

  • Male-specific, e.g. anther, tapetum, pollen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10913953B2 cover?
This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.
Who is the assignee on this patent?
Dowagrosciences Llc, Dow Agrosciences Llc
What technology area does this patent fall under?
Primary CPC classification C12N15/8218. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).